Showing all 9 results
Domperidone Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Rapid-Release / MD Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical stability and instantaneous dissolution of the active ingredient.
Active Ingredient Strength Primary Clinical Function Domperidone Maleate USP/Ph.Eur. 10 mg The Global Antiemetic Standard: The definitive rapid-acting unit utilized globally for the immediate suppression of acute nausea and the acceleration of delayed gastric emptying. Excipients (MD Formulation) Microcrystalline Cellulose / Crospovidone / Mannitol / Aspartame / Peppermint Flavor / Magnesium Stearate Diluent / Superdisintegrant / Cooling Agent / Sweetener / Flavoring (Engineered specifically using elite “Rapid-Burst” superdisintegrants to ensure the Mouth Dissolving tablet shatters in saliva within seconds. This is critical because a vomiting patient physically cannot swallow water or a hard pill without instantly throwing it back up) *Pack Sizes: 10×10 Alu-Alu Blisters (Optimized specifically for strict, short-term gastrointestinal dispensing regimens).
Ergotamine & Caffeine ,Paracetamol & Prochlorperazine Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Density Quad-API Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical stability of the sensitive ergot alkaloid and phenothiazine components.
Active Ingredient Strength Primary Clinical Function Ergotamine Tartrate USP/Ph.Eur. 1 mg The Vascular Terminator (Micro-Dose): The foundational ergot alkaloid required to aggressively constrict pulsing cranial arteries. Caffeine Anhydrous USP/Ph.Eur. 100 mg The Absorption Catalyst: Enhances Ergotamine bioavailability and accelerates onset of action. Paracetamol (Acetaminophen) USP/Ph.Eur. 250 mg The Central Analgesic (Macro-Dose): Provides immediate, broad-spectrum relief from accompanying head and neck pain. Prochlorperazine Maleate USP/Ph.Eur. 2.5 mg The Antiemetic Anchor (Ultra-Micro-Dose): Lethally blocks the CTZ to prevent vomiting and ensure full gastrointestinal absorption of the FDC. Excipients Microcrystalline Cellulose / Croscarmellose Sodium / Povidone K-30 / Magnesium Stearate / Premium Polymeric Film Diluent / Superdisintegrant / Binder / Lubricant (Engineered utilizing extreme multi-stage geometric dilution to flawlessly blend a microscopic 1mg and 2.5mg payload into a massive 250mg/100mg base, guaranteeing absolute content uniformity and zero toxic ‘hot spots’) *Pack Sizes: 10×10 Alu-Alu Blisters (Optimized specifically for strict, heavily limited acute neurology dispensing to prevent ergot toxicity).
Metoclopramide Injection
FreeProduct Composition & Strength
We supply this product as a Sterile Isotonic Solution in glass ampoules.
Active Ingredient Strength Volume Metoclopramide HCl USP/BP 5 mg / ml 2 ml Ampoule (Total 10 mg) Metoclopramide HCl USP/BP 5 mg / ml 10 ml Multi-dose Vial Preservative Sodium Metabisulfite Antioxidant *Pack Sizes: Tray of 10 Ampoules, 50 Ampoules, or 100 Ampoules.
Metoclopramide Tablet
FreeProduct Composition & Packaging Specification
We supply Metoclopramide in the globally standardized therapeutic strength optimized for adult baseline three-times-daily dosage regimens.
Active Ingredient Monograph Calibrated Strength Formulation Delivery Matrix Primary Clinical Function Metoclopramide Hydrochloride USP / BP / IP 10 mg Oral Solid Uncoated Tablet (Scored for micro-dosing titration) The Prokinetic Driver: Accelerates upper gastrointestinal transit and blocks central emetic signals. Excipients Pharma Grade Lactose, Starch, Magnesium Stearate The Core Scaffold: High-solubility matrix engineered for rapid physical disintegration. Ondansetron Injection
FreeProduct Composition & Strength
We supply this product as a Sterile, Clear, Aqueous Solution in glass ampoules or vials.
Active Ingredient Concentration Total Content & Format Ondansetron (as HCl Dihydrate) 2 mg / ml 4 mg in 2 ml Glass Ampoule Ondansetron (as HCl Dihydrate) 2 mg / ml 8 mg in 4 ml Glass Ampoule Excipients Citric Acid / Sodium Citrate pH Buffer System (pH 3.3 to 4.0) *Pack Sizes: Tray of 5/10 Ampoules or Box of 50 Ampoules.
Ondansetron Orally Disintegrating Tablets
FreeProduct Composition & Available Formats
We supply Ondansetron ODT in the two primary compendial configurations required to support initial introductory pediatric dosing up to high-potency surgical and oncological maintenance regimens.
Active Ingredient Monograph Available Strengths Formulation Delivery Matrix Primary Clinical Application Ondansetron Base / Hydrochloride USP / BP / IP 4 mg Fast-Dispersing Hydrophilic Matrix (ODT) Pediatric & General Antiemetic: First-line baseline dosing for acute gastroenteritis, pediatric oncology protocols, and mild post-operative nausea. Ondansetron Base / Hydrochloride USP / BP / IP 8 mg Fast-Dispersing Hydrophilic Matrix (ODT) High-Potency Emetic Control: Advanced strength engineered for highly emetogenic chemotherapy cycles, abdominal radiation protocols, and immediate post-surgical recovery fields. Ondansetron Tablet
FreeProduct Composition & Available Strengths
We supply this critical supportive therapeutic in standard, internationally recognized strengths designed for exact preventative and rescue dosing.
Active Ingredient Available Strengths Primary Clinical Target Ondansetron HCl IP / BP / USP 4 mg Standard Prophylaxis: For moderate emetogenic chemotherapy, general post-operative rescue, and pediatric care. Ondansetron HCl IP / BP / USP 8 mg High-Potency Protection: For highly emetogenic cisplatin-based cancer regimens and severe surgical recovery. Ondansitron Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Engineered Flash-Dispersion ODT or Standard Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant peelable Alu-Alu blister strips to ensure the absolute chemical stability of the highly hygroscopic ODT matrix.
Active Ingredient Strength Primary Clinical Function Ondansetron (as HCl Dihydrate) Ph.Eur./USP 4 mg (ODT / FCT) Pediatric & PONV Standard: Base therapeutic unit for post-operative nausea, severe pediatric gastroenteritis, and mild emetic triggers. Ondansetron (as HCl Dihydrate) Ph.Eur./USP 8 mg (ODT / FCT) Global Oncology Standard: High-dose adult maintenance therapy for highly emetogenic chemotherapy (CINV) and radiation therapy (RINV). Excipients (ODT Formulation) Mannitol / Crospovidone / Aspartame / Colloidal Silicon Dioxide / Premium Mint Flavoring Lyophilized Matrix / Superdisintegrant / Sweetener / Saliva-Stimulating Flavor (Engineered specifically to draw saliva into the tablet matrix, forcing a violent, sub-5-second structural collapse on the tongue without a bitter aftertaste) *Pack Sizes: 10×10 Peelable Alu-Alu Blisters (Optimized specifically for strict oncology and surgical dispensing regimens).
Prochlorperazine Tablets
FreeProchlorperazine Maleate Tablets IP 5 mg
Each Uncoated Tablet contains :
Prochlorperazine Maleate IP 5 mgUsage: – control severe nausea and vomiting
Category: – Antipsychotic / CNS Drugs
Therapeutic category: – Antipsychotic
